Shuttle Pharmaceuticals delays filing quarterly report for period ended June 30, 2026 - SHPH News | RalliesShuttle Pharmaceuticals delays filing quarterly report for period ended June 30, 2026
S
SHPH• Quarterly report filing delayed
- Shuttle Pharmaceuticals filed a Form 12b-25, delaying its Form 10-Q for the quarter ended June 30, 2026.
- Management cited an inability to compile all required disclosure information without unreasonable effort or expense.
- Filing targeted by the fifth calendar day after the prescribed due date.
- Notice flagged expected significant results changes, including R&D expense down 95% to $0.1 million.
- Legal and professional expenses rose 112%; general and administrative expense fell 15% to $2 million.
•
